Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$41.0 - $56.12 $1.17 Million - $1.61 Million
-28,628 Reduced 34.32%
54,786 $2.48 Million
Q4 2022

Feb 14, 2023

BUY
$39.19 - $65.67 $949,926 - $1.59 Million
24,239 Added 40.96%
83,414 $3.39 Million
Q3 2022

Nov 14, 2022

SELL
$61.1 - $83.78 $268,473 - $368,129
-4,394 Reduced 6.91%
59,175 $3.87 Million
Q2 2022

Aug 15, 2022

SELL
$43.23 - $73.83 $5.5 Million - $9.38 Million
-127,116 Reduced 66.66%
63,569 $3.86 Million
Q1 2022

May 16, 2022

BUY
$53.19 - $79.24 $687,002 - $1.02 Million
12,916 Added 7.27%
190,685 $12 Million
Q4 2021

Feb 14, 2022

BUY
$70.09 - $111.29 $12.5 Million - $19.8 Million
177,769 New
177,769 $13.5 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.61B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Lombard Odier Asset Management (Switzerland) Sa Portfolio

Follow Lombard Odier Asset Management (Switzerland) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.